Rigel Pharmaceuticals (RIGL) Operating Margin (QoQ) (2010 - 2026)

Rigel Pharmaceuticals (RIGL) Operating Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Rigel Pharmaceuticals 681.25 Mn 534.56 Mn 54.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,299.00
Dec 31, 2025 -772.00
Sep 30, 2025 -1,918.00
Jun 30, 2025 3,614.00
Mar 31, 2025 -497.00
Dec 31, 2024 350.00
Sep 30, 2024 2,420.00
Jun 30, 2024 2,480.00
Mar 31, 2024 -2,908.00
Dec 31, 2023 2,136.00
Sep 30, 2023 372.00
Jun 30, 2023 2,922.00
Mar 31, 2023 -5,287.00
Dec 31, 2022 8,617.00
Sep 30, 2022 -3,864.00
Jun 30, 2022 11,344.00
Mar 31, 2022 -5,198.00
Dec 31, 2021 -1,310.00
Sep 30, 2021 -4,216.00
Jun 30, 2021 -10,121.00